In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...
For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that ...
The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.
Yes Theory on MSNOpinion
This US city shows why obesity is no longer about personal choice
McAllen, Texas, was once labeled the most obese city in America, drawing national attention to a growing public health crisis ...
The global media leader shares personal experiences with weight and the struggle she had carried for her entire adult life.
The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...
Objectives Functional foods have demonstrated potential in preventing gastrointestinal and musculoskeletal (osteo-related) ...
Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, ...
Eli Lilly and Company recently announced plans to invest more than US$6.00 billion in a new Huntsville, Alabama API facility that will produce small‑molecule and peptide medicines, including its oral ...
Six more states will restrict SNAP purchases of soda, candy and energy drinks, while $700M goes to regenerative agriculture.
The National Kidney Foundation states that millions of people are suffering from kidney diseases and mostly because of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results